WebDisclosure WebDisclosure
Basculer en Français
10832 Companies
235087 Keywords
163979 Articles
125862 Press releases
Headlines Articles Press releases PHARMANEST Remove
  1. Home
  2. Companies
  3. PHARMANEST
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/03/2024 at 15:05, 2 years 2 months ago

    PharmaNest to Present Seven Digital Pathology and AI Communications at EASL 2024

    AI Digital Pathology Fibrosis PharmaNest MASH
  • BRIEF

    published on 06/03/2024 at 15:05, 2 years 2 months ago

    PharmaNest présentera sept communications numériques sur la pathologie et l'IA à l'EASL 2024

    IA Pathologie Numérique Fibrose PharmaNest PURÉE
  • PRESS RELEASE

    published on 06/03/2024 at 15:00, 2 years 2 months ago

    PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation

    PharmaNest showcases FibroNest Ph-FCS digital biomarker for quantifying fibrosis severity and its clinical utility in Phase 2 and Phase 3 studies for patients with Metabolic Associated Steatohepatitis at International Liver Congress - EASL
    Digital Pathology Phase 2 PharmaNest FibroNest Fibrosis Severity
    Logo of PHARMANEST
Accesswire
  • Published on 08/13/2026 at 14:31, 2 hours 6 minutes ago

    Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity

  • Published on 08/13/2026 at 14:15, 2 hours 22 minutes ago

    Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

  • Published on 08/13/2026 at 14:00, 2 hours 37 minutes ago

    AEONIAN Expands Koocanusa Copper Project to Approximately 412 Km(2); Fieldwork Underway Across Four New Target Areas

  • Published on 08/13/2026 at 14:00, 2 hours 37 minutes ago

    Adcore Reports Q2 2026 Results: Gross Margin Expands to 51% as Revenue Grows 10% to CAD$7.2 million and North America Rebounds 27% to CAD$1.5 million

  • Published on 08/13/2026 at 14:00, 2 hours 37 minutes ago

    GameSquare Appoints Tom Wild as Vice President of Creative Strategy for EMEA

View all ACCESSWIRE
EQS Group
  • Published on 08/13/2026 at 15:52, 45 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 08/13/2026 at 15:51, 45 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DNO ASA

  • Published on 08/13/2026 at 15:51, 46 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: JTC plc

  • Published on 08/13/2026 at 15:50, 46 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

  • Published on 08/13/2026 at 15:49, 48 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

View all EQS
Les Echos
  • Published on 08/11/2026 at 17:45, 1 day 22 hours ago

    DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026

  • Published on 08/11/2026 at 17:40, 1 day 22 hours ago

    Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions

  • Published on 08/10/2026 at 18:00, 2 days 22 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 18:00, 2 days 22 hours ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

  • Published on 08/10/2026 at 17:45, 2 days 22 hours ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy